[HTML][HTML] What do we have to know about PD-L1 expression in prostate cancer? A systematic literature review (part 6): correlation of PD-L1 expression with the status of …
…, G Carrieri, L Cormio, J Gandhi, D Nicoli, E Farnetti… - Biomedicines, 2022 - mdpi.com
Pembrolizumab (anti-PD-1) is allowed in selected metastatic castration-resistant prostate
cancer (PC) patients showing microsatellite instability/mismatch repair system deficiency (MSI-…
cancer (PC) patients showing microsatellite instability/mismatch repair system deficiency (MSI-…
VEXAS syndrome: a case series from a single‐center cohort of Italian patients with vasculitis
…, P Castrignanò, D Nicoli, E Farnetti… - Arthritis & …, 2022 - Wiley Online Library
Objective To identify patients with VEXAS syndrome (vacuoles, E1 enzyme, X‐linked,
autoinflammatory, somatic syndrome) from a single‐center cohort of Italian patients with vasculitis, …
autoinflammatory, somatic syndrome) from a single‐center cohort of Italian patients with vasculitis, …
Endothelial nitric oxide synthase gene polymorphisms in Behçet's disease.
…, D Filippini, G Paolazzi, D Nicoli, E Farnetti… - The Journal of …, 2002 - jrheum.org
OBJECTIVE: To analyze potential associations of Glu-Asp298 polymorphism in exon 7 and
4 a/b polymorphism in intron 4 of the endothelial nitric oxide synthase (eNOS) gene with …
4 a/b polymorphism in intron 4 of the endothelial nitric oxide synthase (eNOS) gene with …
Relationship between interleukin 6 promoter polymorphism at position-174, IL-6 serum levels, and the risk of relapse/recurrence in polymyalgia rheumatica.
L Boiardi, B Casali, E Farnetti, N Pipitone… - The Journal of …, 2006 - jrheum.org
OBJECTIVE: To assess the role of -174 G/C promoter polymorphism of interleukin 6 (IL-6) in
the susceptibility to polymyalgia rheumatica (PMR). We also investigated whether this …
the susceptibility to polymyalgia rheumatica (PMR). We also investigated whether this …
Intercellular adhesion molecule 1 gene polymorphisms in polymyalgia rheumatica/giant cell arteritis: association with disease risk and severity.
…, A Ranzi, P Macchioni, D Nicoli, E Farnetti… - The Journal of …, 2000 - europepmc.org
Objective Intercellular adhesion molecule 1 (ICAM-1) is widely distributed in shoulder
synovial membrane of active polymyalgia rheumatica (PMR) and strongly expressed in …
synovial membrane of active polymyalgia rheumatica (PMR) and strongly expressed in …
Intercellular adhesion molecule-1 gene polymorphisms in Behçet's Disease.
…, D Filippini, G Paolazzi, D Nicoli, E Farnetti… - The Journal of …, 2001 - jrheum.org
OBJECTIVE: Intercellular adhesion molecule 1 (ICAM-1) is strongly expressed in vascular
endothelial cells and perivascular inflammatory infiltrates in immunopathologic studies of …
endothelial cells and perivascular inflammatory infiltrates in immunopathologic studies of …
Vascular endothelial growth factor gene polymorphisms in Behçet's disease.
…, P Sarzi-Puttini, D Nicoli, E Farnetti… - The Journal of …, 2004 - jrheum.org
OBJECTIVE: To evaluate potential associations of vascular endothelial growth factor (VEGF)
gene polymorphisms with Behçet's disease (BD) and disease expression. METHODS: …
gene polymorphisms with Behçet's disease (BD) and disease expression. METHODS: …
Vascular endothelial growth factor gene polymorphisms in giant cell arteritis.
L Boiardi, B Casali, D Nicoli, E Farnetti… - The Journal of …, 2003 - jrheum.org
OBJECTIVE: To examine potential associations of vascular endothelial growth factor (VEGF)
gene polymorphisms with giant cell arteritis (GCA) and disease expression, in particular in …
gene polymorphisms with giant cell arteritis (GCA) and disease expression, in particular in …
MicroRNA markers of inflammation and remodelling in temporal arteries from patients with giant cell arteritis
…, F Muratore, A Bisagni, D Nicoli, E Farnetti… - Annals of the …, 2016 - ard.bmj.com
Objectives There is increasing evidence that microRNAs (miRNAs) are deregulated in
autoimmune and cardiovascular diseases. The present study aimed to identify if miRNAs are …
autoimmune and cardiovascular diseases. The present study aimed to identify if miRNAs are …
[HTML][HTML] The clinical relevance of multiple DPYD polymorphisms on patients candidate for fluoropyrimidine based-chemotherapy. An Italian case-control study
…, A Romagnani, R Zamponi, L Tofani, E Farnetti… - British Journal of …, 2019 - nature.com
Background Deleterious polymorphisms in the gene encoding DPD (DPYD) may result in
severe reduction of DPD enzymatic activity that causes life-threatening toxicities when the …
severe reduction of DPD enzymatic activity that causes life-threatening toxicities when the …